Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
02/26/2013 | CA2492068C Assays for assembly of ebola virus nucleocapsids |
02/26/2013 | CA2490415C Asphaltene aggregation in petroleum oil mixtures determined by small angle light scattering |
02/26/2013 | CA2477312C Use of soluble fgl2 as an immunosuppressant |
02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
02/25/2013 | CA2788034A1 Electronic nose apparatus |
02/21/2013 | WO2013026060A1 The islet amyloid polypeptide toxic oligomer is a biomarker of brain alteration in type-2 diabetes mellitus |
02/21/2013 | WO2013026000A1 Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system |
02/21/2013 | WO2013025998A1 Methods, systems, and computer readable media for making base calls in nucleic acid sequencing |
02/21/2013 | WO2013025952A2 Methods and compositions for the treatment and diagnosis of breast cancer |
02/21/2013 | WO2013025909A1 Extrapolation of interpolated sensor data to increase sample throughput |
02/21/2013 | WO2013025904A1 Apparatus, method and computer-accessible medium for determining antigen immunoreactivity in tissue |
02/21/2013 | WO2013025899A1 Vent configuration for a blood sampler |
02/21/2013 | WO2013025862A1 Device and method for use in the collection of whole saliva in research and diagnostics |
02/21/2013 | WO2013025859A1 Extrapolation of interpolated sensor data to increase sample throughput |
02/21/2013 | WO2013025801A2 Control of biofouling in implantable biosensors |
02/21/2013 | WO2013025759A1 Peptide and protein biomarkers for type 1 diabetes mellitus |
02/21/2013 | WO2013025700A1 Phosphocofilin: cofilin co-localization intensity as a predictor of metastic recurrence |
02/21/2013 | WO2013025679A2 Diffuse reflectance infrared fourier transform spectroscopy for characterization of earth materials |
02/21/2013 | WO2013025616A1 Competitive binding dendrimer-based system for analyte detection |
02/21/2013 | WO2013025607A1 Methods of treating amyloidoses with vitamin b12 and test for detecting amyloid-beta peptides |
02/21/2013 | WO2013025598A1 Degranulation indicator and methods of use thereof |
02/21/2013 | WO2013025589A1 Methods and compositions for diagnosis and prognosis in gastric cancer |
02/21/2013 | WO2013025561A1 Sequence read archive interface |
02/21/2013 | WO2013025532A2 Detection of sex steroids |
02/21/2013 | WO2013025527A1 Apparatuses, methods, computer program products, and kits for hi-throughput glycan analysis |
02/21/2013 | WO2013025467A2 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
02/21/2013 | WO2013025332A1 Tagged polymers, water treatment compositions, and methods of their use in aqueous systems |
02/21/2013 | WO2013025322A2 Marker-based prognostic risk score in liver cancer |
02/21/2013 | WO2013025095A1 New method and kit for prediction success of in vitro fertilization |
02/21/2013 | WO2013024918A1 Gene groups serving as observation indexes for cancer progression, and method for detecting the gene groups |
02/21/2013 | WO2013024867A1 Antibody and use thereof |
02/21/2013 | WO2013024843A1 Ceramide derivative and golgi apparatus-labeling fluorescent probe using same |
02/21/2013 | WO2013024821A1 Suspension for parallel reaction, parallel reaction method, and screening method |
02/21/2013 | WO2013024798A1 Method for diagnosing post-operative infection |
02/21/2013 | WO2013024763A1 Production method for nucleic acid aptamer |
02/21/2013 | WO2013024737A1 Method and kit for determining mushroom cultivation period |
02/21/2013 | WO2013024600A1 Information processing system, information processing method, information processing device, and control method and control program therefor |
02/21/2013 | WO2013024517A1 Method for testing for, preventing, and treating infectious disease aspergillus fumigatus; and composition |
02/21/2013 | WO2013024469A1 Methods and compositions for diagnosis of alzheimer's desease |
02/21/2013 | WO2013024272A1 Gene markers for nasopharyngeal carcinoma |
02/21/2013 | WO2013024144A1 Markers for susceptibility to an inhibitor of an src-family kinase |
02/21/2013 | WO2013024100A2 Methods for diagnosing and treating medical conditions associated with oxidative stress |
02/21/2013 | WO2013024031A1 Device for performing an assay |
02/21/2013 | WO2013024028A1 Compounds and compositions for treating proteinopathies |
02/21/2013 | WO2013024024A2 Quality assessment of induced pluripotent cells by referring to splicing signatures of pluripotency |
02/21/2013 | WO2013024015A1 Herg1 and glut-1 in colorectal cancer |
02/21/2013 | WO2013023994A1 New biomarker for the classification of ovarian tumours |
02/21/2013 | WO2013023987A1 Air coupled ultrasonic contactless method for non-destructive determination of defects in laminated structures |
02/21/2013 | WO2013023909A1 Detecting individual analytes by means of magnetic flow measurement |
02/21/2013 | WO2013023770A1 Chromatin profiling assay |
02/21/2013 | WO2013023671A1 Microfluidic device and method for detecting analytes in a flow using electrochemical probes |
02/21/2013 | WO2013023376A1 Microvesicle membrane protein and application thereof |
02/21/2013 | WO2013023299A1 Reservoir sampling tools and methods |
02/21/2013 | WO2013023296A1 Method of diagnosing bacterial infections using bacterial glycoproteins |
02/21/2013 | WO2013023292A1 Fluorescent dyes with large stokes shifts |
02/21/2013 | WO2013023233A1 Method for diagnosis, prognosis or treatment of acute coronary syndrome (acs) comprising measurement of plasma concentration of macrophage migration inhibitory factor (mif) |
02/21/2013 | WO2013006776A3 Systems and methods for genetic data compression |
02/21/2013 | WO2013001383A9 Means for the examination of body fluids |
02/21/2013 | WO2012178030A3 Accurate measurement of glutathione for disease diagnosis and drug metabolite screening |
02/21/2013 | WO2012177940A3 Microfluidic devices and methods for separating and detecting constituents in a fluid sample |
02/21/2013 | WO2012174256A3 Dna methylation profiles in cancer |
02/21/2013 | WO2012162324A3 Method of diagnosing and treating an aspergillus species-associated condition |
02/21/2013 | WO2012162247A3 Monitoring systems for biomass processing systems |
02/21/2013 | WO2012159021A3 Portable hemostasis analyzer |
02/21/2013 | WO2012155057A3 Planar probe and system for measuring dielectric properties of biological materials |
02/21/2013 | WO2012149145A9 Ocular detection of amyloid proteins |
02/21/2013 | WO2012075331A3 Tissue implantable microbiosensor |
02/21/2013 | WO2012048269A8 Systems, methods and devices for measuring growth/oncogenic & migration/metastatic potential |
02/21/2013 | WO2012038565A3 PROTEINS OF THE CRY FAMILY AS MARKERS FOR DETERMINING THE RISK OF DEVELOPING AN α-SYNUCLEINOPATHY OR DETERMINING SAID DISEASE |
02/21/2013 | WO2011116954A8 Prophylaxis of colorectal and gastrointestinal cancer |
02/21/2013 | US20130047274 Cd4 t-cells involved in mammalian host response to epithelial cell infections and uses thereof |
02/21/2013 | US20130046485 Multi-detector gas identification system |
02/21/2013 | US20130046481 Dual-Spectrum Heat Pattern Separation Algorithm For Assessing Chemotherapy Treatment Response And Early Detection |
02/21/2013 | US20130046480 Automatic analysis device and automatic analysis method |
02/21/2013 | US20130046226 Method and a device for monitoring a state of a blood line in a machine for extracorporeal blood treatment |
02/21/2013 | US20130046134 Methods of generating engineered innervated tissue and uses thereof |
02/21/2013 | US20130046093 Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same |
02/21/2013 | US20130046010 Sumo as a marker of cancer development and target for cancer therapy |
02/21/2013 | US20130046009 Rho kinase inhibitors for treatment of mastocytosis and acute myeloid leukemia |
02/21/2013 | US20130045890 Test for male fertility |
02/21/2013 | US20130045889 Biomarkers for hypertensive disorders of pregnancy |
02/21/2013 | US20130045887 Peptide and protein biomarkers for type 1 diabetes mellitus |
02/21/2013 | US20130045884 Means and methods for diagnosing pancreatic cancer |
02/21/2013 | US20130045882 Methods for assessing rna patterns |
02/21/2013 | US20130045879 Methods, computer-accessible medium, and systems for generating a genome wide haplotype sequence |
02/21/2013 | US20130045543 Novel muc1 antibody |
02/21/2013 | US20130045542 New formulations for diagnosis of alzheimer's disease |
02/21/2013 | US20130045501 Detection Device for Detecting Analytes in Liquid Specimen |
02/21/2013 | US20130045495 Elisa for vegf |
02/21/2013 | US20130045493 Diagnosis and treatment of gluten-induced autoimmune diseases |
02/21/2013 | US20130045492 Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
02/21/2013 | US20130045491 Methods for activating t cells |
02/21/2013 | US20130045490 Antibody against mucin 1 (muc1) protein and use of same |
02/21/2013 | US20130045488 Benzocyanine compounds |
02/21/2013 | US20130045487 Method for discovering neurogenic agents |
02/21/2013 | US20130045486 Composition for Cancer Prognosis Prediction Comprising Anti-TMAP/CKAP2 Antibodies |
02/21/2013 | US20130045244 Modified adam disintegrin domain polypeptides and uses thereof |
02/21/2013 | US20130045236 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders |
02/21/2013 | US20130045233 Novel Allergen |